نتائج البحث - "Dimitra Georgopoulou"

المساهمون: Rueda, Oscar M [0000-0003-0008-4884], Giovannetti, Agnese [0000-0001-5207-7243], Chin, Suet-Feung [0000-0001-5697-1082], Carnevalli, Larissa S [0000-0001-7432-0195], Provenzano, Elena [0000-0003-3345-3965], Serra, Violeta [0000-0001-6620-1065], Bressan, Dario [0000-0003-3592-699X], Mills, Gordon B [0000-0002-0144-9614], Ali, H Raza [0000-0001-7587-0906], Caldas, Carlos [0000-0003-3547-1489], Apollo - University of Cambridge Repository, IMAXT Consortium, Ali, H.R., Al Sa'd, M., Alon, S., Aparicio, S., Battistoni, G., Balasubramanian, S., Becker, R., Bodenmiller, B., Boyden, E.S., Bressan, D., Bruna, A., Burger, M., Caldas, C., Callari, M., Cannell, I.G., Casbolt, H., Chornay, N., Cui, Y., Dariush, A., Dinh, K., Emenari, A., Eyal-Lubling, Y., Fan, J., Fatemi, A., Fisher, E., González-Solares, E.A., González-Fernández, C., Goodwin, D., Greenwood, W., Grimaldi, F., Hannon, G.J., Harris, O., Harris, S., Jauset, C., Joyce, J.A., Karagiannis, E.D., Kovačević, T., Kuett, L., Kunes, R., Küpcü, Y.A., Lai, D., Laks, E., Lee, H., Lee, M., Lerda, G., Li, Y., McPherson, A., Millar, N., Mulvey, C.M., Nugent, F., O'Flanagan, C.H., Paez-Ribes, M., Pearsall, I., Qosaj, F., Roth, A.J., Rueda, O.M., Ruiz, T., Sawicka, K., Sepúlveda, L.A., Shah, S.P., Shea, A., Sinha, A., Smith, A., Tavaré, S., Tietscher, S., Vázquez-García, I., Vogl, S.L., Walton, N.A., Wassie, A.T., Watson, S.S., Weselak, J., Wild, S.A., Williams, E., Windhager, J., Whitmarsh, T., Xia, C., Zheng, P., Zhuang, X.

المصدر: Nature Communications
Nature communications, vol. 12, no. 1, pp. 1998
Nature Communications, Vol 12, Iss 1, Pp 1-18 (2021)

مصطلحات موضوعية: 0301 basic medicine, Pyridines, Science, Tumour heterogeneity, Morpholines, Cell, General Physics and Astronomy, Breast Neoplasms, Drug resistance, Mice, SCID, Biology, Animals, Benzamides/pharmacology, Breast Neoplasms/drug therapy, Breast Neoplasms/genetics, Breast Neoplasms/metabolism, Cell Line, Tumor, Drug Resistance, Neoplasm/drug effects, Drug Resistance, Neoplasm/genetics, Female, Heterografts/drug effects, Heterografts/metabolism, Humans, MCF-7 Cells, Mice, Inbred NOD, Mice, Knockout, Morpholines/pharmacology, Piperazines/pharmacology, Protein Kinase Inhibitors/pharmacology, Pyridines/pharmacology, Pyrimidines/pharmacology, Treatment Outcome, Xenograft Model Antitumor Assays/methods, General Biochemistry, Genetics and Molecular Biology, Article, Piperazines, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, medicine, Mass cytometry, Protein Kinase Inhibitors, Multidisciplinary, Genetic heterogeneity, Cancer, General Chemistry, medicine.disease, Biobank, Phenotype, Xenograft Model Antitumor Assays, 3. Good health, 030104 developmental biology, medicine.anatomical_structure, Pyrimidines, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Benzamides, Cancer research, Heterografts

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0712127e8562959156b1ae7983d647f

Find this article in full text from ProQuest

8

Metabolic Imaging Detects Resistance to PI3Kα Inhibition Mediated by Persistent FOXM1 Expression in ER+ Breast Cancer

المساهمون: Institut Català de la Salut, [Ros S, Wright AJ, D'Santos P, Hu DE, Hesketh RL, Lubling Y] Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK. Cancer Research UK Cambridge Cancer Centre, Cambridge, UK. [Oliveira M] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia
Cancer Cell

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, PI3K alpha inhibition, Neoplasms::Neoplasms by Site::Breast Neoplasms [DISEASES], Estrogen receptor, Medicaments antineoplàstics - Ús terapèutic, Mice, SCID, chemistry.chemical_compound, Phosphatidylinositol 3-Kinases, 0302 clinical medicine, Mama - Càncer, Mice, Inbred NOD, Antineoplastic Combined Chemotherapy Protocols, Medicine, Other subheadings::/therapeutic use [Other subheadings], FDG-PET, Fulvestrant, Mice, Knockout, neoplasias::neoplasias por localización::neoplasias de la mama [ENFERMEDADES], medicine.diagnostic_test, Imidazoles, Glucose analog, Magnetic Resonance Imaging, hexokinase 2, Oncology, Receptors, Estrogen, Positron emission tomography, 030220 oncology & carcinogenesis, MCF-7 Cells, Biomarker (medicine), biomarker, Female, medicine.drug, MRI, Class I Phosphatidylinositol 3-Kinases, Breast Neoplasms, Article, 03 medical and health sciences, Breast cancer, breast cancer, Lactate dehydrogenase, Cell Line, Tumor, Animals, Humans, Lactic Acid, terapéutica::protocolos clínicos::protocolos antineoplásicos::protocolos de quimioterapia antineoplásica combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], hyperpolarized [1-(13)C]pyruvate, Protein Kinase Inhibitors, Fluorodeoxyglucose, Oncogene, business.industry, Otros calificadores::/uso terapéutico [Otros calificadores], hyperpolarized [1-13C]pyruvate, Forkhead Box Protein M1, FOXM1, treatment response, lactate dehydrogenase, Therapeutics::Clinical Protocols::Antineoplastic Protocols::Antineoplastic Combined Chemotherapy Protocols [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], medicine.disease, Xenograft Model Antitumor Assays, Oxazepines, Tamoxifen, 030104 developmental biology, chemistry, Drug Resistance, Neoplasm, Cancer research, business